nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiludronate—PTPN1—hematopoietic system—stomach cancer	0.0313	0.141	CbGeAlD
Tiludronate—PTPN1—lymphoid tissue—stomach cancer	0.022	0.0993	CbGeAlD
Tiludronate—PTPN1—digestive system—stomach cancer	0.0218	0.0981	CbGeAlD
Tiludronate—ATP6V1A—hematopoietic system—stomach cancer	0.0187	0.0845	CbGeAlD
Tiludronate—PTPN1—endocrine gland—stomach cancer	0.018	0.081	CbGeAlD
Tiludronate—PTPN1—liver—stomach cancer	0.0162	0.0731	CbGeAlD
Tiludronate—ATP6V1A—pancreas—stomach cancer	0.0153	0.0688	CbGeAlD
Tiludronate—ATP6V1A—lymphoid tissue—stomach cancer	0.0132	0.0595	CbGeAlD
Tiludronate—ATP6V1A—digestive system—stomach cancer	0.013	0.0587	CbGeAlD
Tiludronate—PTPN1—lymph node—stomach cancer	0.0124	0.056	CbGeAlD
Tiludronate—ATP6V1A—bone marrow—stomach cancer	0.012	0.0542	CbGeAlD
Tiludronate—Congenital anomaly—Fluorouracil—stomach cancer	0.0113	0.0633	CcSEcCtD
Tiludronate—Developmental delay—Fluorouracil—stomach cancer	0.0113	0.0633	CcSEcCtD
Tiludronate—ATP6V1A—endocrine gland—stomach cancer	0.0108	0.0485	CbGeAlD
Tiludronate—ATP6V1A—liver—stomach cancer	0.00971	0.0438	CbGeAlD
Tiludronate—Congenital anomaly—Capecitabine—stomach cancer	0.00789	0.0442	CcSEcCtD
Tiludronate—Developmental delay—Capecitabine—stomach cancer	0.00789	0.0442	CcSEcCtD
Tiludronate—ATP6V1A—lymph node—stomach cancer	0.00745	0.0336	CbGeAlD
Tiludronate—Gastrointestinal pain—Floxuridine—stomach cancer	0.00384	0.0215	CcSEcCtD
Tiludronate—Abdominal pain—Floxuridine—stomach cancer	0.00371	0.0208	CcSEcCtD
Tiludronate—Asthenia—Floxuridine—stomach cancer	0.00336	0.0189	CcSEcCtD
Tiludronate—Bone pain—Docetaxel—stomach cancer	0.00323	0.0181	CcSEcCtD
Tiludronate—Diarrhoea—Floxuridine—stomach cancer	0.00321	0.018	CcSEcCtD
Tiludronate—Pain—Mitomycin—stomach cancer	0.00315	0.0176	CcSEcCtD
Tiludronate—Bone pain—Capecitabine—stomach cancer	0.00313	0.0175	CcSEcCtD
Tiludronate—Influenza like illness—Docetaxel—stomach cancer	0.00301	0.0169	CcSEcCtD
Tiludronate—Headache—Floxuridine—stomach cancer	0.00294	0.0165	CcSEcCtD
Tiludronate—Influenza like illness—Capecitabine—stomach cancer	0.00291	0.0163	CcSEcCtD
Tiludronate—Nausea—Floxuridine—stomach cancer	0.00279	0.0156	CcSEcCtD
Tiludronate—Asthenia—Mitomycin—stomach cancer	0.00264	0.0148	CcSEcCtD
Tiludronate—Diarrhoea—Mitomycin—stomach cancer	0.00252	0.0141	CcSEcCtD
Tiludronate—Dizziness—Mitomycin—stomach cancer	0.00243	0.0136	CcSEcCtD
Tiludronate—Headache—Mitomycin—stomach cancer	0.00231	0.0129	CcSEcCtD
Tiludronate—Rhinitis—Irinotecan—stomach cancer	0.00226	0.0126	CcSEcCtD
Tiludronate—Nausea—Mitomycin—stomach cancer	0.00219	0.0123	CcSEcCtD
Tiludronate—Bone pain—Epirubicin—stomach cancer	0.00218	0.0122	CcSEcCtD
Tiludronate—Rhinitis—Fluorouracil—stomach cancer	0.00216	0.0121	CcSEcCtD
Tiludronate—Influenza like illness—Epirubicin—stomach cancer	0.00203	0.0114	CcSEcCtD
Tiludronate—Bone pain—Doxorubicin—stomach cancer	0.00202	0.0113	CcSEcCtD
Tiludronate—Back pain—Irinotecan—stomach cancer	0.00189	0.0106	CcSEcCtD
Tiludronate—Influenza like illness—Doxorubicin—stomach cancer	0.00188	0.0105	CcSEcCtD
Tiludronate—Vertigo—Irinotecan—stomach cancer	0.00176	0.00986	CcSEcCtD
Tiludronate—Myalgia—Fluorouracil—stomach cancer	0.0016	0.00895	CcSEcCtD
Tiludronate—Rhinitis—Docetaxel—stomach cancer	0.00156	0.00874	CcSEcCtD
Tiludronate—Rhinitis—Capecitabine—stomach cancer	0.00151	0.00846	CcSEcCtD
Tiludronate—Dyspepsia—Irinotecan—stomach cancer	0.00141	0.00789	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.00139	0.00782	CcSEcCtD
Tiludronate—Pain—Irinotecan—stomach cancer	0.00137	0.00766	CcSEcCtD
Tiludronate—Dyspepsia—Fluorouracil—stomach cancer	0.00135	0.00755	CcSEcCtD
Tiludronate—Back pain—Docetaxel—stomach cancer	0.00131	0.00734	CcSEcCtD
Tiludronate—Pain—Fluorouracil—stomach cancer	0.00131	0.00734	CcSEcCtD
Tiludronate—Gastrointestinal pain—Irinotecan—stomach cancer	0.00131	0.00733	CcSEcCtD
Tiludronate—Back pain—Capecitabine—stomach cancer	0.00127	0.00711	CcSEcCtD
Tiludronate—Abdominal pain—Irinotecan—stomach cancer	0.00126	0.00708	CcSEcCtD
Tiludronate—Vertigo—Capecitabine—stomach cancer	0.00118	0.0066	CcSEcCtD
Tiludronate—Myalgia—Docetaxel—stomach cancer	0.00115	0.00646	CcSEcCtD
Tiludronate—Arthralgia—Docetaxel—stomach cancer	0.00115	0.00646	CcSEcCtD
Tiludronate—Asthenia—Irinotecan—stomach cancer	0.00115	0.00643	CcSEcCtD
Tiludronate—Arthralgia—Capecitabine—stomach cancer	0.00112	0.00626	CcSEcCtD
Tiludronate—Myalgia—Capecitabine—stomach cancer	0.00112	0.00626	CcSEcCtD
Tiludronate—Diarrhoea—Irinotecan—stomach cancer	0.00109	0.00613	CcSEcCtD
Tiludronate—Dizziness—Irinotecan—stomach cancer	0.00106	0.00592	CcSEcCtD
Tiludronate—Rhinitis—Epirubicin—stomach cancer	0.00105	0.0059	CcSEcCtD
Tiludronate—Diarrhoea—Fluorouracil—stomach cancer	0.00105	0.00587	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MAPK3—stomach cancer	0.00102	0.00171	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—JUN—stomach cancer	0.00102	0.00169	CbGpPWpGaD
Tiludronate—Dizziness—Fluorouracil—stomach cancer	0.00101	0.00567	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.00101	0.00564	CcSEcCtD
Tiludronate—Headache—Irinotecan—stomach cancer	0.001	0.00561	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—KISS1R—stomach cancer	0.000997	0.00166	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GLI3—stomach cancer	0.000997	0.00166	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KISS1R—stomach cancer	0.000997	0.00166	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GLI3—stomach cancer	0.000997	0.00166	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—SERPINE1—stomach cancer	0.000996	0.00166	CbGpPWpGaD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MYC—stomach cancer	0.000995	0.00166	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—ALB—stomach cancer	0.000995	0.00166	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6ST—stomach cancer	0.000987	0.00165	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—KRAS—stomach cancer	0.000976	0.00163	CbGpPWpGaD
Tiludronate—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000975	0.00546	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—MAPK1—stomach cancer	0.000973	0.00162	CbGpPWpGaD
Tiludronate—Rhinitis—Doxorubicin—stomach cancer	0.000973	0.00545	CcSEcCtD
Tiludronate—Dyspepsia—Docetaxel—stomach cancer	0.000973	0.00545	CcSEcCtD
Tiludronate—ATP6V1A—Disease—RPL18—stomach cancer	0.000967	0.00161	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RPL13—stomach cancer	0.000967	0.00161	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—RHOA—stomach cancer	0.000961	0.0016	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MAPK8—stomach cancer	0.000961	0.0016	CbGpPWpGaD
Tiludronate—Headache—Fluorouracil—stomach cancer	0.000959	0.00538	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—RBP1—stomach cancer	0.000951	0.00159	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RBP1—stomach cancer	0.000951	0.00159	CbGpPWpGaD
Tiludronate—Nausea—Irinotecan—stomach cancer	0.000949	0.00532	CcSEcCtD
Tiludronate—Pain—Docetaxel—stomach cancer	0.000945	0.0053	CcSEcCtD
Tiludronate—Back pain—Methotrexate—stomach cancer	0.000944	0.00529	CcSEcCtD
Tiludronate—Dyspepsia—Capecitabine—stomach cancer	0.000942	0.00528	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—KRAS—stomach cancer	0.000919	0.00153	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RNF43—stomach cancer	0.000917	0.00153	CbGpPWpGaD
Tiludronate—Pain—Capecitabine—stomach cancer	0.000915	0.00513	CcSEcCtD
Tiludronate—Nausea—Fluorouracil—stomach cancer	0.000909	0.0051	CcSEcCtD
Tiludronate—Gastrointestinal pain—Docetaxel—stomach cancer	0.000903	0.00506	CcSEcCtD
Tiludronate—ATP6V1A—Disease—RPS21—stomach cancer	0.000902	0.0015	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RPS15—stomach cancer	0.000902	0.0015	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—PIK3CA—stomach cancer	0.000897	0.00149	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CASP10—stomach cancer	0.000885	0.00148	CbGpPWpGaD
Tiludronate—Back pain—Epirubicin—stomach cancer	0.000883	0.00495	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—PPP2R1A—stomach cancer	0.000883	0.00147	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6R—stomach cancer	0.000881	0.00147	CbGpPWpGaD
Tiludronate—Vertigo—Methotrexate—stomach cancer	0.000877	0.00491	CcSEcCtD
Tiludronate—Gastrointestinal pain—Capecitabine—stomach cancer	0.000875	0.0049	CcSEcCtD
Tiludronate—Abdominal pain—Docetaxel—stomach cancer	0.000873	0.0049	CcSEcCtD
Tiludronate—PTPN1—Immune System—MX1—stomach cancer	0.000854	0.00142	CbGpPWpGaD
Tiludronate—Abdominal pain—Capecitabine—stomach cancer	0.000846	0.00474	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—PIK3CA—stomach cancer	0.000845	0.00141	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MAPK3—stomach cancer	0.00084	0.0014	CbGpPWpGaD
Tiludronate—Arthralgia—Methotrexate—stomach cancer	0.000831	0.00466	CcSEcCtD
Tiludronate—Myalgia—Methotrexate—stomach cancer	0.000831	0.00466	CcSEcCtD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—HRAS—stomach cancer	0.000829	0.00138	CbGpPWpGaD
Tiludronate—Vertigo—Epirubicin—stomach cancer	0.00082	0.0046	CcSEcCtD
Tiludronate—Back pain—Doxorubicin—stomach cancer	0.000817	0.00458	CcSEcCtD
Tiludronate—PTPN1—Interferon Signaling—MAPK3—stomach cancer	0.000804	0.00134	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—MAPK1—stomach cancer	0.000799	0.00133	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling by Insulin receptor—IL6—stomach cancer	0.000794	0.00132	CbGpPWpGaD
Tiludronate—Asthenia—Docetaxel—stomach cancer	0.000793	0.00444	CcSEcCtD
Tiludronate—PTPN1—PDGFR-beta signaling pathway—HRAS—stomach cancer	0.000781	0.0013	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—BIRC2—stomach cancer	0.000779	0.0013	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—FYN—stomach cancer	0.000778	0.0013	CbGpPWpGaD
Tiludronate—Myalgia—Epirubicin—stomach cancer	0.000777	0.00436	CcSEcCtD
Tiludronate—Arthralgia—Epirubicin—stomach cancer	0.000777	0.00436	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—WWOX—stomach cancer	0.000775	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—WWOX—stomach cancer	0.000775	0.00129	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CTSL—stomach cancer	0.000773	0.00129	CbGpPWpGaD
Tiludronate—Asthenia—Capecitabine—stomach cancer	0.000767	0.0043	CcSEcCtD
Tiludronate—Vertigo—Doxorubicin—stomach cancer	0.000759	0.00426	CcSEcCtD
Tiludronate—Diarrhoea—Docetaxel—stomach cancer	0.000756	0.00424	CcSEcCtD
Tiludronate—PTPN1—Immune System—MALT1—stomach cancer	0.000753	0.00126	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ALDOB—stomach cancer	0.000748	0.00125	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—LGALS3—stomach cancer	0.000747	0.00125	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000739	0.00123	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RPL15—stomach cancer	0.000733	0.00122	CbGpPWpGaD
Tiludronate—Diarrhoea—Capecitabine—stomach cancer	0.000732	0.0041	CcSEcCtD
Tiludronate—Dizziness—Docetaxel—stomach cancer	0.000731	0.0041	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000726	0.00407	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—WIF1—stomach cancer	0.000721	0.0012	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRH4—stomach cancer	0.000721	0.0012	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRH4—stomach cancer	0.000721	0.0012	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—WIF1—stomach cancer	0.000721	0.0012	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NPM1—stomach cancer	0.00072	0.0012	CbGpPWpGaD
Tiludronate—Myalgia—Doxorubicin—stomach cancer	0.000719	0.00403	CcSEcCtD
Tiludronate—Arthralgia—Doxorubicin—stomach cancer	0.000719	0.00403	CcSEcCtD
Tiludronate—Dizziness—Capecitabine—stomach cancer	0.000707	0.00397	CcSEcCtD
Tiludronate—Dyspepsia—Methotrexate—stomach cancer	0.000701	0.00393	CcSEcCtD
Tiludronate—ATP6V1A—Disease—RBP4—stomach cancer	0.000695	0.00116	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—PIK3CA—stomach cancer	0.000693	0.00116	CbGpPWpGaD
Tiludronate—Headache—Docetaxel—stomach cancer	0.000692	0.00388	CcSEcCtD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—VEGFA—stomach cancer	0.000685	0.00114	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RPS26—stomach cancer	0.000684	0.00114	CbGpPWpGaD
Tiludronate—Pain—Methotrexate—stomach cancer	0.000681	0.00382	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000679	0.00381	CcSEcCtD
Tiludronate—ATP6V1A—Disease—PPIA—stomach cancer	0.000678	0.00113	CbGpPWpGaD
Tiludronate—Headache—Capecitabine—stomach cancer	0.00067	0.00376	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL1B—stomach cancer	0.00067	0.00112	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKAB1—stomach cancer	0.000665	0.00111	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKAB1—stomach cancer	0.000665	0.00111	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PLAU—stomach cancer	0.000664	0.00111	CbGpPWpGaD
Tiludronate—Nausea—Docetaxel—stomach cancer	0.000656	0.00368	CcSEcCtD
Tiludronate—Dyspepsia—Epirubicin—stomach cancer	0.000656	0.00368	CcSEcCtD
Tiludronate—Gastrointestinal pain—Methotrexate—stomach cancer	0.000651	0.00365	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—CAV1—stomach cancer	0.000649	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—MAPK3—stomach cancer	0.000648	0.00108	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—APOA1—stomach cancer	0.000647	0.00108	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RNF43—stomach cancer	0.000642	0.00107	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KISS1—stomach cancer	0.000642	0.00107	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RNF43—stomach cancer	0.000642	0.00107	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KISS1—stomach cancer	0.000642	0.00107	CbGpPWpGaD
Tiludronate—PTPN1—Insulin Signaling—HRAS—stomach cancer	0.000641	0.00107	CbGpPWpGaD
Tiludronate—Pain—Epirubicin—stomach cancer	0.000637	0.00357	CcSEcCtD
Tiludronate—Nausea—Capecitabine—stomach cancer	0.000635	0.00356	CcSEcCtD
Tiludronate—Abdominal pain—Methotrexate—stomach cancer	0.00063	0.00353	CcSEcCtD
Tiludronate—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000628	0.00352	CcSEcCtD
Tiludronate—PTPN1—Immune System—IRF1—stomach cancer	0.000626	0.00104	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PRKCB—stomach cancer	0.000617	0.00103	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	0.000617	0.00103	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Epirubicin—stomach cancer	0.000609	0.00342	CcSEcCtD
Tiludronate—Dyspepsia—Doxorubicin—stomach cancer	0.000607	0.0034	CcSEcCtD
Tiludronate—Pain—Doxorubicin—stomach cancer	0.00059	0.00331	CcSEcCtD
Tiludronate—Abdominal pain—Epirubicin—stomach cancer	0.000589	0.0033	CcSEcCtD
Tiludronate—PTPN1—Immune System—IL1RN—stomach cancer	0.000583	0.000972	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RPS19—stomach cancer	0.000581	0.00097	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—AKR1C3—stomach cancer	0.000581	0.00097	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FST—stomach cancer	0.000572	0.000955	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FST—stomach cancer	0.000572	0.000955	CbGpPWpGaD
Tiludronate—Asthenia—Methotrexate—stomach cancer	0.000571	0.0032	CcSEcCtD
Tiludronate—ATP6V1A—Disease—ENO1—stomach cancer	0.000567	0.000945	CbGpPWpGaD
Tiludronate—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000564	0.00316	CcSEcCtD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—STAT3—stomach cancer	0.000562	0.000936	CbGpPWpGaD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—APOA1—stomach cancer	0.00056	0.000934	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RGS2—stomach cancer	0.000552	0.000921	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—GAST—stomach cancer	0.000552	0.000921	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RGS2—stomach cancer	0.000552	0.000921	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—GAST—stomach cancer	0.000552	0.000921	CbGpPWpGaD
Tiludronate—Abdominal pain—Doxorubicin—stomach cancer	0.000545	0.00306	CcSEcCtD
Tiludronate—Diarrhoea—Methotrexate—stomach cancer	0.000545	0.00305	CcSEcCtD
Tiludronate—PTPN1—Immune System—CD44—stomach cancer	0.000544	0.000908	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—MAPK3—stomach cancer	0.000537	0.000895	CbGpPWpGaD
Tiludronate—PTPN1—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	0.000535	0.000893	CbGpPWpGaD
Tiludronate—Asthenia—Epirubicin—stomach cancer	0.000535	0.003	CcSEcCtD
Tiludronate—Dizziness—Methotrexate—stomach cancer	0.000527	0.00295	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—FGG—stomach cancer	0.000524	0.000873	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGG—stomach cancer	0.000524	0.000873	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RPS6—stomach cancer	0.000514	0.000857	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—SERPINE1—stomach cancer	0.000514	0.000856	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—ALB—stomach cancer	0.000513	0.000855	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HBEGF—stomach cancer	0.000512	0.000853	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—MAPK1—stomach cancer	0.000511	0.000851	CbGpPWpGaD
Tiludronate—Diarrhoea—Epirubicin—stomach cancer	0.00051	0.00286	CcSEcCtD
Tiludronate—ATP6V1A—Signaling Pathways—PRKAA1—stomach cancer	0.000504	0.00084	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKAA1—stomach cancer	0.000504	0.00084	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CD44—stomach cancer	0.000503	0.000838	CbGpPWpGaD
Tiludronate—Headache—Methotrexate—stomach cancer	0.000499	0.0028	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—RHOA—stomach cancer	0.000495	0.000826	CbGpPWpGaD
Tiludronate—Asthenia—Doxorubicin—stomach cancer	0.000495	0.00277	CcSEcCtD
Tiludronate—Dizziness—Epirubicin—stomach cancer	0.000493	0.00276	CcSEcCtD
Tiludronate—PTPN1—Hemostasis—NOS3—stomach cancer	0.00049	0.000818	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RBP4—stomach cancer	0.000487	0.000812	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RBP4—stomach cancer	0.000487	0.000812	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—KRAS—stomach cancer	0.000482	0.000804	CbGpPWpGaD
Tiludronate—Nausea—Methotrexate—stomach cancer	0.000473	0.00265	CcSEcCtD
Tiludronate—ATP6V1A—Disease—HBEGF—stomach cancer	0.000472	0.000788	CbGpPWpGaD
Tiludronate—Diarrhoea—Doxorubicin—stomach cancer	0.000472	0.00264	CcSEcCtD
Tiludronate—Headache—Epirubicin—stomach cancer	0.000467	0.00262	CcSEcCtD
Tiludronate—PTPN1—Immune System—PPP2R1A—stomach cancer	0.000463	0.000772	CbGpPWpGaD
Tiludronate—Dizziness—Doxorubicin—stomach cancer	0.000456	0.00256	CcSEcCtD
Tiludronate—ATP6V1A—Transmembrane transport of small molecules—ALB—stomach cancer	0.000444	0.00074	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—PIK3CA—stomach cancer	0.000443	0.000739	CbGpPWpGaD
Tiludronate—Nausea—Epirubicin—stomach cancer	0.000443	0.00248	CcSEcCtD
Tiludronate—Headache—Doxorubicin—stomach cancer	0.000432	0.00242	CcSEcCtD
Tiludronate—ATP6V1A—Disease—PPP2R1A—stomach cancer	0.000427	0.000712	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HSPB1—stomach cancer	0.000419	0.000698	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HSPB1—stomach cancer	0.000419	0.000698	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AGTR2—stomach cancer	0.000419	0.000698	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AGTR2—stomach cancer	0.000419	0.000698	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—F2R—stomach cancer	0.000414	0.00069	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—BMP2—stomach cancer	0.000414	0.00069	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—F2R—stomach cancer	0.000414	0.00069	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—BMP2—stomach cancer	0.000414	0.00069	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—HRAS—stomach cancer	0.00041	0.000683	CbGpPWpGaD
Tiludronate—Nausea—Doxorubicin—stomach cancer	0.00041	0.0023	CcSEcCtD
Tiludronate—PTPN1—Immune System—FYN—stomach cancer	0.000408	0.00068	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—AKR1C3—stomach cancer	0.000407	0.000679	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—AKR1C3—stomach cancer	0.000407	0.000679	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HTR1A—stomach cancer	0.000403	0.000672	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HTR1A—stomach cancer	0.000403	0.000672	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SMAD4—stomach cancer	0.000397	0.000662	CbGpPWpGaD
Tiludronate—PTPN1—Cytokine Signaling in Immune system—IL6—stomach cancer	0.000392	0.000654	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ANXA1—stomach cancer	0.000389	0.000649	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ANXA1—stomach cancer	0.000389	0.000649	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—FGFR2—stomach cancer	0.000383	0.000639	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADRB1—stomach cancer	0.000377	0.000628	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADRB1—stomach cancer	0.000377	0.000628	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FYN—stomach cancer	0.000377	0.000628	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERCC2—stomach cancer	0.000362	0.000604	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RPS6—stomach cancer	0.00036	0.0006	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RPS6—stomach cancer	0.00036	0.0006	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—FGFR2—stomach cancer	0.000354	0.00059	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—VEGFA—stomach cancer	0.000353	0.000589	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IRS2—stomach cancer	0.000351	0.000585	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MTHFR—stomach cancer	0.00034	0.000568	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MAPK3—stomach cancer	0.000334	0.000557	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HBEGF—stomach cancer	0.000331	0.000552	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HBEGF—stomach cancer	0.000331	0.000552	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IRS2—stomach cancer	0.000324	0.00054	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PRKCB—stomach cancer	0.000324	0.00054	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6ST—stomach cancer	0.000322	0.000538	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—MAPK1—stomach cancer	0.000318	0.00053	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CAV1—stomach cancer	0.000314	0.000524	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APOA1—stomach cancer	0.000313	0.000522	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ADRB2—stomach cancer	0.000305	0.000509	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ADRB2—stomach cancer	0.000305	0.000509	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—KRAS—stomach cancer	0.0003	0.000501	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PPP2R1A—stomach cancer	0.000299	0.000499	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PPP2R1A—stomach cancer	0.000299	0.000499	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6ST—stomach cancer	0.000298	0.000496	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CASP8—stomach cancer	0.000288	0.000481	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6R—stomach cancer	0.000288	0.00048	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—APC—stomach cancer	0.000286	0.000477	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDH1—stomach cancer	0.000285	0.000475	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SMAD4—stomach cancer	0.000278	0.000463	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SMAD4—stomach cancer	0.000278	0.000463	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—PIK3CA—stomach cancer	0.000276	0.00046	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—TP53—stomach cancer	0.000267	0.000445	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6R—stomach cancer	0.000266	0.000443	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FYN—stomach cancer	0.000264	0.00044	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FYN—stomach cancer	0.000264	0.00044	CbGpPWpGaD
Tiludronate—PTPN1—Hemostasis—HRAS—stomach cancer	0.000255	0.000426	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—SERPINE1—stomach cancer	0.000249	0.000415	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—FGFR2—stomach cancer	0.000248	0.000413	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—FGFR2—stomach cancer	0.000248	0.000413	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—ERBB2—stomach cancer	0.000241	0.000401	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—RHOA—stomach cancer	0.00024	0.0004	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—NOS3—stomach cancer	0.000237	0.000396	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IRS2—stomach cancer	0.000227	0.000378	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IRS2—stomach cancer	0.000227	0.000378	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1B—stomach cancer	0.000223	0.000371	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—ERBB2—stomach cancer	0.000222	0.00037	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CAV1—stomach cancer	0.00022	0.000367	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CAV1—stomach cancer	0.00022	0.000367	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APOA1—stomach cancer	0.000219	0.000366	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APOA1—stomach cancer	0.000219	0.000366	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL1B—stomach cancer	0.000219	0.000365	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PTGS2—stomach cancer	0.000217	0.000362	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—JUN—stomach cancer	0.000212	0.000354	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PRKCB—stomach cancer	0.000209	0.000349	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PRKCB—stomach cancer	0.000209	0.000349	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6ST—stomach cancer	0.000208	0.000348	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6ST—stomach cancer	0.000208	0.000348	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1B—stomach cancer	0.000206	0.000343	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—CDKN1A—stomach cancer	0.000206	0.000343	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK8—stomach cancer	0.000201	0.000335	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—APC—stomach cancer	0.0002	0.000334	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—APC—stomach cancer	0.0002	0.000334	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—CDKN1A—stomach cancer	0.00019	0.000316	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6R—stomach cancer	0.000186	0.00031	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6R—stomach cancer	0.000186	0.00031	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—STAT3—stomach cancer	0.000183	0.000306	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK3—stomach cancer	0.000175	0.000292	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—SERPINE1—stomach cancer	0.000174	0.00029	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—SERPINE1—stomach cancer	0.000174	0.00029	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—STAT3—stomach cancer	0.000169	0.000282	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—RHOA—stomach cancer	0.000168	0.00028	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—RHOA—stomach cancer	0.000168	0.00028	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—MAPK1—stomach cancer	0.000167	0.000278	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—EGFR—stomach cancer	0.000167	0.000278	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—NOS3—stomach cancer	0.000166	0.000277	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—NOS3—stomach cancer	0.000166	0.000277	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAPK3—stomach cancer	0.000162	0.00027	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—KRAS—stomach cancer	0.000157	0.000263	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MYC—stomach cancer	0.000157	0.000262	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—ERBB2—stomach cancer	0.000156	0.000259	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—ERBB2—stomach cancer	0.000156	0.000259	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—MAPK1—stomach cancer	0.000154	0.000257	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—EGFR—stomach cancer	0.000154	0.000257	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CXCL8—stomach cancer	0.000147	0.000246	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CXCL8—stomach cancer	0.000147	0.000246	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—KRAS—stomach cancer	0.000145	0.000242	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—PIK3CA—stomach cancer	0.000145	0.000241	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1B—stomach cancer	0.000144	0.00024	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1B—stomach cancer	0.000144	0.00024	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CCND1—stomach cancer	0.000137	0.000229	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CCND1—stomach cancer	0.000137	0.000229	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—JUN—stomach cancer	0.000137	0.000229	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—JUN—stomach cancer	0.000137	0.000229	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—HRAS—stomach cancer	0.000134	0.000223	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—PIK3CA—stomach cancer	0.000134	0.000223	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MMP9—stomach cancer	0.000133	0.000222	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MMP9—stomach cancer	0.000133	0.000222	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—CDKN1A—stomach cancer	0.000133	0.000222	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—CDKN1A—stomach cancer	0.000133	0.000222	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK8—stomach cancer	0.00013	0.000216	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK8—stomach cancer	0.00013	0.000216	CbGpPWpGaD
Tiludronate—PTPN1—Immune System—IL6—stomach cancer	0.000128	0.000214	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—HRAS—stomach cancer	0.000124	0.000206	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—VEGFA—stomach cancer	0.00012	0.0002	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—VEGFA—stomach cancer	0.00012	0.0002	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—STAT3—stomach cancer	0.000119	0.000198	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—STAT3—stomach cancer	0.000119	0.000198	CbGpPWpGaD
Tiludronate—ATP6V1A—Disease—IL6—stomach cancer	0.000118	0.000197	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK3—stomach cancer	0.000113	0.000189	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK3—stomach cancer	0.000113	0.000189	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MYC—stomach cancer	0.00011	0.000184	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MYC—stomach cancer	0.00011	0.000184	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—MAPK1—stomach cancer	0.000108	0.00018	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—MAPK1—stomach cancer	0.000108	0.00018	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—EGFR—stomach cancer	0.000108	0.00018	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—EGFR—stomach cancer	0.000108	0.00018	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—KRAS—stomach cancer	0.000102	0.00017	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—KRAS—stomach cancer	0.000102	0.00017	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—PIK3CA—stomach cancer	9.35e-05	0.000156	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—PIK3CA—stomach cancer	9.35e-05	0.000156	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—TP53—stomach cancer	9.05e-05	0.000151	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—TP53—stomach cancer	9.05e-05	0.000151	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—HRAS—stomach cancer	8.66e-05	0.000144	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—HRAS—stomach cancer	8.66e-05	0.000144	CbGpPWpGaD
Tiludronate—ATP6V1A—Signaling Pathways—IL6—stomach cancer	8.28e-05	0.000138	CbGpPWpGaD
Tiludronate—PTPN1—Signaling Pathways—IL6—stomach cancer	8.28e-05	0.000138	CbGpPWpGaD
